Loading…
Reported covered position: Staff Assistant, Sen. Lamar Alexander; Professional Staff, Health, Education, Labor, and Pensions (HELP) Cmte.; Legislative Correspondent, Sen. Lamar Alexander
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
FDA Modernization Act 3.0
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; use of sunscreen in schools to prevent sunburns in children; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
FDA Modernization Act 3.0
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
UNITED MITOCHONDRIAL DISEASE FOUNDATION via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health.
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| NATIONAL ASSOCIATION OF EMS PHYSICIANS |
| 2 |
| 2025 |
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; use of sunscreen in schools to prevent sunburns in children; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
FDA Modernization Act 3.0
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; use of sunscreen in schools to prevent sunburns in children; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
FDA Modernization Act 3.0
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Medical Foods and Formulas Access Act of 2025
Client: UNITED MITOCHONDRIAL DISEASE FOUNDATION · Firm: HOLLAND & KNIGHT LLP
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Medical Foods and Formulas Access Act of 2025
Client: UNITED MITOCHONDRIAL DISEASE FOUNDATION · Firm: HOLLAND & KNIGHT LLP
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Medical Foods and Formulas Access Act of 2025
Client: UNITED MITOCHONDRIAL DISEASE FOUNDATION · Firm: HOLLAND & KNIGHT LLP
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Medical Foods and Formulas Access Act of 2025
Client: UNITED MITOCHONDRIAL DISEASE FOUNDATION · Firm: HOLLAND & KNIGHT LLP
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Medical Foods and Formulas Access Act of 2025
Client: UNITED MITOCHONDRIAL DISEASE FOUNDATION · Firm: HOLLAND & KNIGHT LLP
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Medical Foods and Formulas Access Act of 2025
Client: UNITED MITOCHONDRIAL DISEASE FOUNDATION · Firm: HOLLAND & KNIGHT LLP
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
FDA Modernization Act 3.0
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; use of sunscreen in schools to prevent sunburns in children; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
FDA Modernization Act 3.0
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; use of sunscreen in schools to prevent sunburns in children; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
FDA Modernization Act 3.0
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; use of sunscreen in schools to prevent sunburns in children; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
FDA Modernization Act 3.0
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Advancing Research for Chronic Pain Act of 2026
Client: PROTECTING ACCESS TO PAIN RELIEF COALITION · Firm: HOLLAND & KNIGHT LLP
Policies and future legislation related to drug labeling and chronic pain surveillance; S. 5041 - Advancing Research for Chronic Pain Act.
FDA Modernization Act 3.0
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
When Minutes Count for Emergency Medical Patients Act
Client: NATIONAL ASSOCIATION OF EMS PHYSICIANS · Firm: HOLLAND & KNIGHT LLP
Development of legislation regarding reimbursement for medical directors and ambulance agencies; changing Medicare reimbursement regarding treatment in place; inquiring about finalization of DEA Rule for administration of emergency medications on ambulances; drug shortages; H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services.
When Minutes Count for Emergency Medical Patients Act
Client: NATIONAL ASSOCIATION OF EMS PHYSICIANS · Firm: HOLLAND & KNIGHT LLP
Development of legislation regarding reimbursement for medical directors and ambulance agencies; changing Medicare reimbursement regarding treatment in place; inquiring about finalization of DEA Rule for administration of emergency medications on ambulances; drug shortages; H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services.
SAFE Sunscreen Standards Act
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in the Coronavirus Aid, Relief, and Economic Security (CARES Act; Public Law 116-136); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA); the SAFE Sunscreen Standards Act (H.R. 3686).
SAFE Sunscreen Standards Act
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
SAFE Sunscreen Standards Act
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in the Coronavirus Aid, Relief, and Economic Security (CARES Act; Public Law 116-136); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA); the SAFE Sunscreen Standards Act (H.R. 3686).
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in the Coronavirus Aid, Relief, and Economic Security (CARES Act; Public Law 116-136); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA); the SAFE Sunscreen Standards Act (H.R. 3686).
FDA Modernization Act 3.0
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Saving Organs One Flight at a Time Act
Client: ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS · Firm: HOLLAND & KNIGHT LLP
IPPS provisions related to Medicare organ procurement costs; H.R. 4362 - Saving Organs One Flight at a Time Act; requesting guidance on decertification.
Saving Organs One Flight at a Time Act
Client: ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS · Firm: HOLLAND & KNIGHT LLP
IPPS provisions related to Medicare organ procurement costs; H.R. 4362 - Saving Organs One Flight at a Time Act; requesting guidance on decertification.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Security (CARES Act); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the FY 2025 House and Senate appropriations for the Food and Drug Administration (H.R. 9027 and S. 4690); skin cancer prevention for outdoor workers; use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA).
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION · Firm: HOLLAND & KNIGHT LLP
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Security (CARES Act); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the FY 2025 House and Senate appropriations for the Food and Drug Administration (H.R. 9027 and S. 4690); skin cancer prevention for outdoor workers; use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA).
PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ABRIDGE AI, INC. via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROTECTING ACCESS TO PAIN RELIEF COALITION via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Policies and future legislation related to drug labeling and chronic pain surveillance; S. 5041 - Advancing Research for Chronic Pain Act.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION via HOLLAND & KNIGHT LLP
2026 · first_quarter · 1A
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; use of sunscreen in schools to prevent sunburns in children; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; use of sunscreen in schools to prevent sunburns in children; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PROTECTING ACCESS TO PAIN RELIEF COALITION via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
Policies and future legislation related to drug labeling and chronic pain surveillance.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
UNITED MITOCHONDRIAL DISEASE FOUNDATION via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health.
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABRIDGE AI, INC. via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION via HOLLAND & KNIGHT LLP
2026 · first_quarter · Q1
Implementation of the sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2027 appropriations for the Food and Drug Administration; use of sunscreen in schools to prevent sunburns in children; FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PROTECTING ACCESS TO PAIN RELIEF COALITION via HOLLAND & KNIGHT LLP
2026 · first_quarter · Q1
Policies and future legislation related to drug labeling and chronic pain surveillance.
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
UNITED MITOCHONDRIAL DISEASE FOUNDATION via HOLLAND & KNIGHT LLP
2026 · first_quarter · Q1
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health.
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FPMCM, LLC D/B/A FAST PACE HEALTH via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Educate regarding state proposals to expand care and services pursuant to the Rural Health Transformation Fund.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Sunscreen provisions in the reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing for over-the-counter drugs; FDA Modernization Act 3.0 (S. 355; H.R. 2821).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PROTECTING ACCESS TO PAIN RELIEF COALITION via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Policies and future legislation related to drug labeling and chronic pain surveillance.
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Medicare Organ Procurement Organization Issues, General Organ Procurement Education, Organ Donor Referral bills and FAA issues related to organ donation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION via HOLLAND & KNIGHT LLP
2025 · third_quarter · Q3
Reauthorization of the Food and Drug Administration (FDA) Over-the-Counter Monograph User Fee Act (OMUFA); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; the SAFE Sunscreen Standards Act (H.R. 3686); FDA policy on animal testing.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PROTECTING ACCESS TO PAIN RELIEF COALITION via HOLLAND & KNIGHT LLP
2025 · third_quarter · Q3
Policies and future legislation related to drug labeling and chronic pain surveillance.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS via HOLLAND & KNIGHT LLP
2025 · third_quarter · Q3
Medicare Organ Procurement Organization Issues, General Organ Procurement Education, Organ Donor Referral bills and FAA issues related to organ donation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
FPMCM, LLC D/B/A FAST PACE HEALTH via HOLLAND & KNIGHT LLP
2025 · third_quarter · RR
Pursuit of funding for the Rural Transformation Program.
PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION via HOLLAND & KNIGHT LLP
2025 · second_quarter · Q2
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in the Coronavirus Aid, Relief, and Economic Security (CARES Act; Public Law 116-136); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA); the SAFE Sunscreen Standards Act (H.R. 3686).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF EMS PHYSICIANS via HOLLAND & KNIGHT LLP
2025 · second_quarter · 2A
Development of legislation regarding reimbursement for medical directors and ambulance agencies; changing Medicare reimbursement regarding treatment in place; inquiring about finalization of DEA Rule for administration of emergency medications on ambulances; drug shortages; H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF EMS PHYSICIANS via HOLLAND & KNIGHT LLP
2025 · second_quarter · Q2
Development of legislation regarding reimbursement for medical directors and ambulance agencies; changing Medicare reimbursement regarding treatment in place; inquiring about finalization of DEA Rule for administration of emergency medications on ambulances; drug shortages; H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS via HOLLAND & KNIGHT LLP
2025 · second_quarter · Q2
Medicare Organ Procurement Organization Issues, General Organ Procurement Education, Organ Donor Referral bills and FAA issues related to organ donation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION via HOLLAND & KNIGHT LLP
2025 · first_quarter · Q1
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in the Coronavirus Aid, Relief, and Economic Security (CARES Act; Public Law 116-136); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the FY 2026 House and Senate appropriations for the Food and Drug Administration; skin cancer prevention for outdoor workers; use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA); nomination of new HHS and FDA leadership.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS via HOLLAND & KNIGHT LLP
2025 · first_quarter · Q1
Medicare Organ Procurement Organization Issues, General Organ Procurement Education, Organ Donor Referral bills and FAA issues related to organ donation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION via HOLLAND & KNIGHT LLP
2024 · fourth_quarter · Q4
Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Security (CARES Act); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the FY 2025 House and Senate appropriations for the Food and Drug Administration (H.R. 9027 and S. 4690); skin cancer prevention for outdoor workers; use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS via HOLLAND & KNIGHT LLP
2024 · fourth_quarter · Q4
Requesting guidance on decertification; general organ procurement education; donor care units.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS via HOLLAND & KNIGHT LLP
2024 · third_quarter · Q3
Requesting guidance on decertification; general organ procurement education; donor care units.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS via HOLLAND & KNIGHT LLP
2024 · second_quarter · Q2
IPPS provisions related to Medicare organ procurement costs; H.R. 4362 - Saving Organs One Flight at a Time Act; requesting guidance on decertification.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS via HOLLAND & KNIGHT LLP
2024 · first_quarter · Q1
IPPS provisions related to Medicare organ procurement costs; H.R. 4362 - Saving Organs One Flight at a Time Act; requesting guidance on decertification.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE